Jyong Biotech Valuation Multiples

Jyong Biotech Overview

About Jyong Biotech

Jyong Biotech Ltd is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia (primarily Taiwan and mainland China). It has been dedicated to the research and development of new drugs with high safety and efficacy. It has been developing a series of drug candidates, including one core drug candidate at NDA stage, one clinical-stage key drug candidate and other preclinical-stage drug candidates.

Founded

2018

HQ

Employees

32

Website

healtheverbiotech.com

Sectors

Plant-Based Food

Financials (FY)

Revenue: —

EBITDA: ($2M)

EV

$218M

Valuation Multiples

Multiples.vc

Start free trial

Jyong Biotech Financials

Jyong Biotech reported last fiscal year revenue of — and negative EBITDA of ($2M).

In the same fiscal year, Jyong Biotech generated ($2M) in EBITDA losses and had net loss of ($3M).

Jyong Biotech P&L

In the most recent fiscal year, Jyong Biotech reported revenue of — and EBITDA of ($2M).

Jyong Biotech expects next 12-month revenue of XXX and NTM EBITDA of XXX

Jyong Biotech Stock Performance

Jyong Biotech has current market cap of $200M, and enterprise value of $218M.

Jyong Biotech's stock price is $2.69.

Jyong Biotech Valuation Multiples

Jyong Biotech trades at (116.9x) EV/EBITDA.

Jyong Biotech Financial Valuation Multiples

As of April 11, 2026, Jyong Biotech has market cap of $200M and EV of $218M.

Equity research analysts estimate Jyong Biotech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Jyong Biotech has a P/E ratio of (66.1x).

Jyong Biotech Margins & Growth Rates

Jyong Biotech's revenue in the last fiscal year grew by —.

Jyong Biotech's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.

Jyong Biotech Public Comps

See public comps and valuation multiples for other Plant-Based Food comps.

Jyong Biotech M&A Activity

Jyong Biotech acquired XXX companies to date.

Last acquisition by Jyong Biotech was on XXXXXXXX, XXXXX. Jyong Biotech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Jyong Biotech Investment Activity

Jyong Biotech invested in XXX companies to date.

Jyong Biotech made its latest investment on XXXXXXXX, XXXXX. Jyong Biotech invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).